Skip to main content
Equibles

Squarepoint Ops LLC

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1642575 NEW YORK, NY
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$346,095
+$230,211 QoQ
Shares Held
113,474
+273.1% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 163 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Derivatives in LRMR

reported options exposure · as of Mar 31, 2024
CallValue
$0
CallShares
0
PutValue
$303,600
PutShares
40,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. LRMR ranks #171 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in LRMR

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $346,095 113,474
2025-12-31 $115,884 30,416
2024-12-31 $108,634 28,071
2024-09-30 $280,307 42,795
2024-06-30 $216,470 29,858
2024-03-31 $303,600 40,000
2023-03-31 $138,867 30,655